From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Husband and Wife’s New Year’s Resolutions: Become Advocates for Organ Donation, Meet the Donor Family and Inspire Love and Peace Amongst Others
Today the SBIR was reauthorized for a period of 6 years, ending September 30, 2017. This includes STTR, and what was the Commercialization Pilot Program (CPP), now to be known as the Commercialization Readiness Program (CRP). The reauthorization was included in the National Defense Authorization Act of 2012 (NDAA) HR.1540. The bill has been sent to the […]
Technique evaluates heterogeneity of tumors using novel image analysis algorithms with standard immunohistochemistry techniques Press Release via 2011 AZBio Fast Lane Award winner Flagship Biosciences.
AZ FAST GRANT – 2011 Technology Commercialization Assistance now available from the Arizona Commerce Authority Download the application as a PDF Document Download the application as a Word Document
- America's Role in the World- Why Leading Globally Matters for Arizona
- BIO 2019 - It Starts with One
- 06/03/2019 - 06/06/2019
- RESI Philadelphia
- The Rocky Mountain Life Science Investor & Partnering Conference
- 09/04/2019 - 09/05/2019
- The MedTech Conference 2019
- 09/23/2019 - 09/25/2019